Focused Ultrasound Foundation

01/10/2026

Focused Ultrasound for Essential Tremor

Rick has essential tremor, a benign tremor that often left him embarrassed in public and frustrated with everyday tasks. After undergoing a focused ultrasound treatment, Rick can now hold his hand steady for the first time since childhood.

Watch Rick’s journey: https://www.fusfoundation.org/profiles/ricks-story/

01/09/2026

Email from ISTU ISTU 2026 Abstracts Submissions and Registration Are Open Register Now! Webinar January 22 / 23 Our next webinar will feature Arik Hananel, M.D., MBA, BsCs, CEO and CoFounder from FUS

01/09/2026

The Foundation is proud to designate University College London (UCL) and King's College London as a Focused Ultrasound Center of Excellence.

Both London institutions are leaders in advancing focused ultrasound for the treatment of prostate cancer, movement disorders, liver tumors, brain tumors, and more. This joint designation recognizes their substantial contributions to the field and their combined strengths, including aligned therapeutic strategies and highly collaborative operating models.

Learn more: https://ow.ly/QN9g50XU17y

01/09/2026

On December 30, 2025, People’s Daily named Focused Ultrasound Ablation by Haifu Technology as a 2025 People’s Ingenuity Technology.

The program recognizes technologies with clear innovation, industrial value, and social impact. Haifu’s focused ultrasound solution delivers non invasive treatment with no incision, no bleeding, and no radiation. Ultrasound energy is precisely focused on the lesion, creating rapid thermal ablation while preserving surrounding tissue and organ function.

Haifu has led focused ultrasound development from research to clinical use for over two decades. Milestones include export to the University of Oxford, EU CE certification, and permanent collection by the National Museum of China.

Chinese innovation, built on precision and clinical value.

01/09/2026

01/08/2026

Not only does focused ultrasound for essential tremor or Parkinson’s-related tremors help reduce shaking—it can also improve daily function and quality of life.

According to Insightec’s clinical data, patients report:
• Better stability for fine motor tasks
• Improved control when eating, writing, or holding objects
• Greater independence in everyday activities
A meaningful advancement that helps restore confidence and daily stability.

Take the quiz to see if this treatment may be right for you:

https://app.smartsheet.com/b/form/52ffd867600e4c548977af86dd38b8d0

01/08/2026

Early Clinical Trial Results of Focused Ultrasound for Pediatric Brain Cancer

Learn more 🔗 https://zurl.co/weH2s

01/07/2026

Focused Ultrasound for Low Back Pain

FUSMobile’s Neurolyser XR system has been granted De Novo clearance by the FDA for the treatment of chronic low back pain. This marks a significant milestone for patients, as low back pain affects millions of people and is often treated with opioids, injections, or invasive procedures.

The first-of-its-kind device, which uses focused ultrasound to ablate sensory nerves in the spinal facet joints, is also approved in Europe, Canada, and the UK. Learn more: https://www.fusfoundation.org/posts/focused-ultrasound-for-low-back-pain-first-of-its-kind-device-receives-fda-clearance/

01/06/2026

The Foundation and the Society of Interventional Oncology recently presented a webinar on minimally invasive approaches for treating pancreatic cancer. This devastating disease affects more than 500,000 people worldwide each year and has an alarmingly high mortality rate.

Expert physicians shared insights on several treatment modalities, including focused ultrasound, and discussed strategies for recruiting participants into clinical trials evaluating new technologies.

The full recording is now available:

The Focused Ultrasound Foundation and the Society of Interventional Oncology (SIO) presented a special webinar on Wednesday, November 19, 2025,...

01/05/2026

Focused Ultrasound for Glioblastoma: Recently published clinical trial results report, for the first time, a possible survival benefit among newly diagnosed glioblastoma (GBM) patients treated with focused ultrasound + temozolomide (or TMZ, a chemotherapy drug).

Researchers used focused ultrasound to noninvasively open the blood-brain barrier in GBM patients before administering TMZ. When compared with a matched control group, a 40% increase in overall survival was observed.

Read more: https://www.fusfoundation.org/posts/glioblastoma-clinical-trial-focused-ultrasound-blood-brain-barrier-opening-is-safe-provides-possible-survival-benefit/

01/05/2026

Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is a non-invasive treatment option for essential tremor (ET). Its use is often limited to patients with a skull density ratio (SDR) above 0.4, despite reports of positive outcomes in those with lower SDR.